Phase 1b/Study of VX15/2503 in Combination With Avelumab in Advanced Non-small Cell Lung Cancer

Trial Profile

Phase 1b/Study of VX15/2503 in Combination With Avelumab in Advanced Non-small Cell Lung Cancer

Recruiting
Phase of Trial: Phase I/II

Latest Information Update: 16 Oct 2017

At a glance

  • Drugs Avelumab (Primary) ; VX 15 (Primary)
  • Indications Non-small cell lung cancer
  • Focus Adverse reactions
  • Acronyms CLASSICAL-Lung
  • Sponsors Vaccinex
  • Most Recent Events

    • 11 Oct 2017 Status changed from not yet recruiting to recruiting.
    • 28 Aug 2017 Status changed from planning to not yet recruiting.
    • 22 Oct 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top